Gerald Vervoort

1.1k total citations
21 papers, 801 citations indexed

About

Gerald Vervoort is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Gerald Vervoort has authored 21 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 7 papers in Nephrology and 4 papers in Molecular Biology. Recurrent topics in Gerald Vervoort's work include Blood Pressure and Hypertension Studies (8 papers), Chronic Kidney Disease and Diabetes (4 papers) and Dialysis and Renal Disease Management (4 papers). Gerald Vervoort is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Chronic Kidney Disease and Diabetes (4 papers) and Dialysis and Renal Disease Management (4 papers). Gerald Vervoort collaborates with scholars based in Netherlands, United States and Australia. Gerald Vervoort's co-authors include Paul Smits, Jack F.M. Wetzels, B. A. J. Veldman, Cees J. Tack, Abraham A. Kroon, Wilko Spiering, Peter W. de Leeuw, P. A. Doevendans, Jos A. Lutterman and Jo H. M. Berden and has published in prestigious journals such as Diabetes Care, Kidney International and Hypertension.

In The Last Decade

Gerald Vervoort

21 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Vervoort Netherlands 15 272 203 187 158 122 21 801
Juan García‐Puig Spain 17 550 2.0× 307 1.5× 144 0.8× 60 0.4× 125 1.0× 45 1.0k
Manuel Botana Spain 13 204 0.8× 194 1.0× 161 0.9× 79 0.5× 68 0.6× 32 617
Aytekin Oğuz Türkiye 16 166 0.6× 316 1.6× 78 0.4× 156 1.0× 131 1.1× 86 958
Haralambos Milionis Greece 16 268 1.0× 172 0.8× 121 0.6× 82 0.5× 98 0.8× 29 1.0k
Elisabeth Ejerblad Sweden 10 160 0.6× 113 0.6× 377 2.0× 98 0.6× 153 1.3× 23 1.1k
Rita Rachmani Israel 14 345 1.3× 493 2.4× 326 1.7× 78 0.5× 114 0.9× 25 1.0k
P. Hougaard Denmark 6 192 0.7× 348 1.7× 132 0.7× 140 0.9× 90 0.7× 10 818
Gemma Currie United Kingdom 14 267 1.0× 277 1.4× 234 1.3× 61 0.4× 189 1.5× 22 1.0k
Katy G. Wilkens United States 4 123 0.5× 384 1.9× 274 1.5× 104 0.7× 107 0.9× 8 727
E Cacès France 15 147 0.5× 294 1.4× 92 0.5× 97 0.6× 109 0.9× 25 900

Countries citing papers authored by Gerald Vervoort

Since Specialization
Citations

This map shows the geographic impact of Gerald Vervoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Vervoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Vervoort more than expected).

Fields of papers citing papers by Gerald Vervoort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Vervoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Vervoort. The network helps show where Gerald Vervoort may publish in the future.

Co-authorship network of co-authors of Gerald Vervoort

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Vervoort. A scholar is included among the top collaborators of Gerald Vervoort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Vervoort. Gerald Vervoort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Anne F.M., Stephan P. Keijmel, Renate G. van der Molen, et al.. (2018). Autoimmunity and B-cell dyscrasia in acute and chronic Q fever: A review of the literature. European Journal of Internal Medicine. 54. 6–12. 11 indexed citations
2.
Haan, Nynke Scherpbier‐de, W.J.C. de Grauw, Gerald Vervoort, et al.. (2016). Quality of chronic kidney disease management in primary care: a retrospective study. Scandinavian Journal of Primary Health Care. 34(1). 73–80. 34 indexed citations
3.
4.
5.
6.
Haan, Nynke Scherpbier‐de, Gerald Vervoort, Chris van Weel, et al.. (2013). Effect of shared care on blood pressure in patients with chronic kidney disease: a cluster randomised controlled trial. British Journal of General Practice. 63(617). e798–e806. 33 indexed citations
7.
Zuilen, Arjan D. van, Jan A.J.G. van den Brand, Michiel L. Bots, et al.. (2013). Nurse Practitioner Care Improves Renal Outcome in Patients with CKD. Journal of the American Society of Nephrology. 25(2). 390–398. 77 indexed citations
8.
Zuilen, Arjan D. van, Michiel L. Bots, Ingeborg van der Tweel, et al.. (2012). Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney International. 82(6). 710–717. 68 indexed citations
9.
Haan, Nynke Scherpbier‐de, et al.. (2012). A pharmacy medication alert system based on renal function in older patients. British Journal of General Practice. 62(601). e525–e529. 14 indexed citations
10.
Jansen, Henry, Gerald Vervoort, Marinette van der Graaf, Rinke Stienstra, & Cees J. Tack. (2012). Liver fat content is linked to inflammatory changes in subcutaneous adipose tissue in type 2 diabetes patients. Clinical Endocrinology. 79(5). 661–666. 9 indexed citations
11.
Rops, Angelique L., M.J. van den Hoven, B. A. J. Veldman, et al.. (2011). Urinary heparanase activity in patients with Type 1 and Type 2 diabetes. Nephrology Dialysis Transplantation. 27(7). 2853–2861. 39 indexed citations
12.
Scherpbier, Nynke, W.J.C. de Grauw, Jack F.M. Wetzels, & Gerald Vervoort. (2010). Acute nierinsufficiëntie bij combinatie RAAS-remmer en dehydratie. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 154(28). 1324–1328. 2 indexed citations
13.
Zuilen, Arjan D. van, Peter J. Blankestijn, Marjolijn van Buren, et al.. (2010). Quality of care in patients with chronic kidney disease is determined by hospital specific factors. Nephrology Dialysis Transplantation. 25(11). 3647–3654. 15 indexed citations
14.
Zuilen, Arjan D. van, Peter J. Blankestijn, Michiel L. Bots, et al.. (2006). Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]. Trials. 7(1). 30–4. 32 indexed citations
15.
Vervoort, Gerald, Jack F.M. Wetzels, Jos A. Lutterman, et al.. (2002). Atrial natriuretic peptide–induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients. American Journal of Kidney Diseases. 40(1). 9–15. 17 indexed citations
16.
Veldman, B. A. J., Wilko Spiering, P. A. Doevendans, et al.. (2002). The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. Journal of Hypertension. 20(10). 2023–2027. 215 indexed citations
17.
Vervoort, Gerald, Jos A. Lutterman, Paul Smits, Jo H. M. Berden, & Jack F.M. Wetzels. (1999). Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients. Journal of Hypertension. 17(Supplement). 1911–1916. 18 indexed citations
18.
Vervoort, Gerald, et al.. (1999). The Role of Adenosine in Insulin-Induced Vasodilation. Journal of Cardiovascular Pharmacology. 34(3). 374–380. 10 indexed citations
19.
Vervoort, Gerald, et al.. (1999). Elevated Skeletal Muscle Blood Flow in Noncomplicated Type 1 Diabetes Mellitus. Hypertension. 34(5). 1080–1085. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan García‐Puig Breakdown of academic impact, for papers by Manuel Botana Breakdown of academic impact, for papers by Aytekin Oğuz Breakdown of academic impact, for papers by Haralambos Milionis Breakdown of academic impact, for papers by Elisabeth Ejerblad Breakdown of academic impact, for papers by Rita Rachmani Breakdown of academic impact, for papers by P. Hougaard Breakdown of academic impact, for papers by Gemma Currie Breakdown of academic impact, for papers by Katy G. Wilkens Breakdown of academic impact, for papers by E Cacès
Rankless by CCL
2026